Whole Exome Sequencing in Neurogenetic Diagnostic Odysseys: An Argentinian Experience
Authors:
- Marta CordobaMCMarta Cordoba
- Sergio Rodriguez-QuirogaSRSergio Rodriguez-Quiroga
- Patricia VegaPVPatricia Vega
- Hernan AmartinoHAHernan Amartino
- Cecilia Vazquez-DusefanteCVCecilia Vazquez-Dusefante
- Nancy MedinaNMNancy Medina
- Dolores Gonzalez-MoronDGDolores Gonzalez-Moron
- Marcelo Andres KauffmanMKMarcelo Andres Kauffman
Preprint
Abstract
Clinical variability is a hallmark of neurogenetic disorders. They involve widespread neurological entities such as neuropathies, ataxias, myopathies, mitochondrial encephalopathies, leukodystrophies, epilepsy and intellectual disabilities. Despite the use of considerable time and resources, the diagnostic yield in this field has been disappointingly low. This etiologic search has been called a “diagnostic odyssey” for many families. Whole exome sequencing (WES) has proved to be useful across a variety of genetic disorders, simplifying the odyssey of many patients and their families and leading to subsequent changes in clinical management in a proportion of them. Although a diagnostic yield of about 30% in neurogenetic disorders can be extrapolated from the results of large series that have included other medical conditions as well, there are not specific reports assessing its utility in a setting such as ours: a neurogeneticist led academic group serving in a low-income country. Herein, we report on a series of our first 40 consecutive cases that were selected for WES in a research-based neurogenetics laboratory. We demonstrated the clinical utility of WES in our patient cohort, obtaining a diagnostic yield of 40% (95% CI, 24.8%-55.2%), describing cases in which clinical management was altered, and suggesting the potential cost-effectiveness of WES as a single test by examining the number and types of tests that were performed prior to WES which added up to a median cost of $3537.6 ($2892 to $5084) for the diagnostic odysseys experienced by our cohort.Keywords
This publication has 41 references indexed in Scilit:
- A New Kv1.2 Channelopathy Underlying Cerebellar AtaxiaJournal of Biological Chemistry, 2010
- De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraineNeurology, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation familiesJournal of Medical Genetics, 2009
- A Defect in the Ionotropic Glutamate Receptor 6 Gene (GRIK2) Is Associated with Autosomal Recessive Mental RetardationThe American Journal of Human Genetics, 2007
- Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosumNature Genetics, 2007
- Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysisAnnals of Neurology, 2006
- Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorderEuropean Journal of Human Genetics, 2003
- Two families with Wilson disease in which siblings showed different phenotypesJournal of Human Genetics, 2002
- Severe limb girdle muscular dystrophy in Spanish gypsies: further evidence for a founder mutation in the γ-sarcoglycan geneEuropean Journal of Human Genetics, 1998